Case study

Landscape Assessment for
Development of Bi-Specific
Antibody using Available

Client

A European Biotech Company

Objective

Prioritization of portfolio by looking at the current portfolio and aligning it with the present market opportunity in EU and US

Stakeholders

CEO, CSO

Area of Focus

Bi-specific Antibodies

Key Questions
Our Solution

Built a market opportunity roadmap and prioritized client’s portfolio so they focus on the product that has the maximum probability of commercial success

ArtiXio Advantage

Domain Experts

Commercial, Scientific, Medical, IP

Proprietary Platform

Knowledgebase of Antibodies

Technology Suite

Dynamic Platform ArtTech

KOL Network

Dynamic models for future prioritization of portfolio

Value Created

Value Created icon
Prioritization of portfolio with a detailed Market Opportunity Roadmap, which helped the company position their technology to the investors and raise funds for further development
error: Content is protected !!